This agrees with our findings that the overall survival was significantly lower in the group that showed low-TRIM52-AS1 expression than in the group with high-TRIM52-AS1 expression (Figure 8G) in CC patients. This evidence concerns the gene TRIM52 and cholangiocarcinoma.